Skip to main content
Equibles

Legal & General Group Plc

Position in VCEL — Vericel Corp

CIK 764068 London, X0
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,144,378
+$1,487,262 QoQ
Shares Held
115,630
+1.7% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. VCEL ranks #47 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in VCEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,144,378 115,630
2026-03-31 $3,657,116 113,681
2025-12-31 $4,534,305 125,918
2025-09-30 $4,254,616 135,196
2025-06-30 $5,921,299 139,161
2025-03-31 $6,168,580 138,247
2024-12-31 $7,665,709 139,605
2024-09-30 $5,721,536 135,421
2024-06-30 $6,228,025 135,746
2024-03-31 $6,978,014 134,141
2023-12-31 $4,744,961 133,248
2023-09-30 $4,499,857 134,244
2023-06-30 $5,047,227 134,342
2023-03-31 $3,388,042 115,554
2022-12-31 $2,992,697 113,618
2022-09-30 $2,574,062 110,951
2022-06-30 $2,775,792 110,238
2022-03-31 $4,171,712 109,150
2021-12-31 $4,324,650 110,042
2021-09-30 $5,158,452 105,706
2021-06-30 $5,114,287 97,415
2021-03-31 $7,016,409 126,308
2020-12-31 $212,700 6,888
2020-09-30 $155,299 8,381
2020-06-30 $114,208 8,264
2020-03-31 $74,249 8,097